Gritstone files for IPO, forges deal with bluebird

Gritstone Oncology Inc. (Emeryville, Calif.) filed for an IPO on NASDAQ and announced a deal with bluebird bio Inc. (NASDAQ:BLUE) to develop cell therapies using natural T cell receptors (TCRs) against tumor-specific targets.

Gritstone filed to raise up to $80 million in an offering underwritten by

Read the full 455 word article

User Sign In